CTOs on the Move

Framingham Heart Study

www.framinghamheartstudy.org

 
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Framingham Heart Study raised $38M on 04/16/2019

Similar Companies

Floyd Lee Locums

Floyd Lee Locums provides an elite concierge experience to physicians, CRNAs, nurse practitioners, physician assistants, and other healthcare providers searching for new career opportunities. Founded by industry veterans Matt Floyd and Natasha Lee, Floyd Lee Locums is a locum tenens healthcare staffing organization with over 60 years of combined experience.

Dreyfus Health Foundation

Dreyfus Health Foundation is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hexagon Labs

Hexagon Labs is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Doe and Ingalls

Doe and Ingalls is a Medford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.